ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Ambrisentan OrPha 5 mg, Filmtabletten - 30
67500001 OrPha Swiss GmbH
Ambrisentan OrPha 5 mg, Filmtabletten16.12.2022
Generic16.12.2022
Ambrisentan (C02KX02) 
WHO-DDD15.12.2027
02.07.10.30
02.07.10. 
B  
Yes 
IPCI
990.57Yes
    
10 %1093.70
7680675000012Synthetika
  
Composition
ambrisentanum 5 mg, cellulosum microcristallinum, lactosum monohydricum 47.5 mg, carmellosum natricum conexum corresp. natrium 0.16 mg, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, E 129 0.022 mg, lecithinum ex soja, E 171, pro compresso obducto.
Packungsbestandteile
Coated tablets 
 
Active AgentDose
Ambrisentanum5 mg
BAG: Active AgentDose
Ambrisentanum5 mg
 
Inactive agentsDoseadditional_information
Carmellosum Natricum Conexum  
Cellulosum Microcristallinum  
E 1290.022 mgcolor.
E 171 color.
Lactose Monohydrate47.5 mg 
Lecithinum ex Soja  
Macrogol3350  
Magnesii Stearas  
Poly(Alcohol Vinylicus) Überzug
Pro Compresso Obducto  
Talcum  
 
Source
Data was imported : 12.01.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home